跳至主要内容
临床试验/NCT04141449
NCT04141449进行中(未招募)2 期

A Multilevel Intervention (Potlako+) to Improve Timely Cancer Detection and Treatment

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 874 人开始时间: 2020年11月18日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
入组人数
874
试验地点
1
主要终点
Duration of combined Appraisal and Help-seeking intervals

研究概览

简要总结

This study evaluates whether the Potlako+ intervention of community education, clinical provider support, and patient navigation can improve access to cancer case for patients presenting with symptoms of cancer. Half of communities will receive the Potlako+ intervention, while the other communities will continue to receive standard programs.

详细描述

The Potlako+ trial is a pair-matched, community-randomized study involving 20 rural and peri-urban communities in Botswana (population ~190,100 with ~100,000 30 years or older). Communities will be randomized 1:1 to the Potlako+ intervention versus standard care. The goal of the intervention is to identify individuals with symptoms/signs suggestive of cancer and expedite diagnosis (and treatment).

The trial includes a community education component focused on cancer awareness and importance of early diagnosis and a patient navigation component that aims to expedite the diagnostic evaluation. Community education will be directed at approximately 50,000 community residents (30 years and older). We anticipate approximately 1500 cancer suspects will be identified by their clinic providers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Botswana citizen
  • Age 30 years or older
  • engaged in longitudinal care for chronic health problem
  • resident of study community

排除标准

  • Involuntary incarceration
  • Educational messaging could interfere with clinical management or increase distress in the opinion or clinic or research staff
  • Cancer suspects
  • Inclusion Criteria:
  • Botswana citizen
  • Age 30 years or older
  • resident of study community
  • Recorded as a cancer suspect by clinic staff
  • Exclusion Criteria
  • Involuntary incarceration
  • Unable or unwilling to provide confirmation of informed consent
  • Already engaged in oncology care

结局指标

主要结局

Duration of combined Appraisal and Help-seeking intervals

时间窗: Baseline

Number of days from patient symptom awareness to first clinic visit, among patients with moderate or high probability of cancer

Duration of Pre-Treatment interval

时间窗: From date of cancer diagnosis to date of cancer treatment up to 365 days

Number of days from cancer diagnosis to cancer treatment

Proportion of patients treated with limited stage cancer

时间窗: From date of cancer diagnosis to date of cancer treatment up to 365 days

Among patients with confirmed cancer, proportion treated with stage I/II disease

Duration of Diagnostic interval

时间窗: From date of first clinic visit to date of cancer diagnosis or diagnosis excluding cancer, up to 365 days

Number of days from first clinic visit to cancer diagnosis or diagnosis excluding cancer, among patients with moderate or high probability of cancer

Incidence of curative-intent treatment

时间窗: From intervention start up to trial end at 1825 days

Cumulative incidence (cases per standardized population) of initiation of curative-intent cancer treatment

次要结局

  • Incident low probability cancer syndromes(Baseline)
  • Incident invasive procedures in cancer suspects(From intervention start up to trial end at 1825 days)
  • Patients treated for cancer(From date of cancer diagnosis to date of cancer treatment up to 365 days)
  • Final diagnosis within 8 weeks(From date of first clinic visit to date of cancer diagnosis or diagnosis excluding cancer, up to 56 days)
  • Cancer presenting as emergency(From date of cancer diagnosis to date of cancer treatment up to 7 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Scott Lee Dryden-Peterson

Assistant Professor

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验